Research

Hormonal

Roux-en-Y gastric bypass (RYGBP) surgery significantly increases postprandial secretion of active GLP-1 and total PYY in morbidly obese subjects, which is associated with decreased hunger and increased satiety.

For patients undergoing Roux-en-Y gastric bypass, the surgery triggers a significant increase in satiety hormones (GLP-1 and PYY) after eating, which directly reduces hunger and increases feelings of fullness. This hormonal shift is a key driver of weight loss, distinct from simple stomach size reduction.

ModerateSupportsMEDIUM confidence
Our data show that RYGBP is associated with an improvement in the active GLP-1 and total PYY response to a liquid-meal intake. Moreover, we provide circumstantial evidence for a potential role of these gastrointestinal hormones on the decreased appetite after RYGBP.
Rosa Morı́nigo et al. · The Journal of Clinical Endocrinology & Metabolism · 2006

Why this rating

Small sample size (n=9) and lack of a direct surgical control group (only BMI-matched non-surgical controls), though prospective design is strong.

Source

Glucagon-Like Peptide-1, Peptide YY, Hunger, and Satiety after Gastric Bypass Surgery in Morbidly Obese Subjects

Rosa Morı́nigo et al. · The Journal of Clinical Endocrinology & Metabolism · 2006

DOI 10.1210/jc.2005-0904

cohort · n=15Cited 397×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →